Rh Disease Clinical Trial
Official title:
Circulating microRNAs Expression as Predictors of Clinical Response in Rheumatoid Arthritis Patients Treated With Green Tea
The correlation of circulating serum miR-125ba and miR-146a expression and clinical response to green tea therapy were analysed in RA patients.Clinical response to green tea therapy for 24 weeks was calculated from DAS28 scores. Whereas , a decrease of 1.2 points or above in DAS28 scores at 24 weeks of treatment compared with baseline was defined as clinical response according to the EULAR response criteria.A ready-made solutions containing the primers and probes for human miR-146a and miR-125ba (Applied Biosystems, Foster City, CA) and real-time RT-PCR was estimated using an ABI 7300 system (Applied Bio systems).
1. participants: A total of 100 subjects (aged 18-65 years) who were diagnosed as RA with
moderate to severe activity at the division of rheumatology and clinical immunology at
Mansoura University were evaluated in this study.
2. patients were evaluated for therapeutic response at baseline and 12, and 24 weeks of
green tea therapy. All patients with RA were subjected for estimation of ESR, CRP,
disease activity score in 28 joints (DAS28), patient's global assessment (PGA), and
health assessment questionnaire damage index (HAQ-DI) at each visits (0 week, 12 weeks,
and 24 weeks).
3. Pain intensity was assessed by using a standard VAS of 100 mm previously validated to
chronic and acute pains.
4. Clinical response to green tea therapy for 24 weeks was calculated from DAS28 scores.
5. human miR-146a and miR-125ba were isolated and subjected to RT-PCR analysis
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02287896 -
Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus
|
Phase 2 |